| Discover | Research | Trust | Convert | Experience | Return & Advocate | |
|---|---|---|---|---|---|---|
| DigitalSEO · Paid · AI search | AI & SEO hit Searches 'waterless skincare France' — Peruda appears in Google, ChatGPT, Perplexity |
Ingredient education SEO content on Amazonian bioactives, INCI, EU regulation context |
Press coverage Elle, Marie Claire, Grazia + Moniteur des Pharmacies from month 6 |
CRM sequence Retargeting + email trial offer. EU regulation as urgency driver |
Peruda World AI Personalised skin recovery journey. Onboarding via CRM from day one |
35% repeat rate CRM reactivation. Reviews and referrals restart the discovery loop |
| D2Cperuda.fr · subscription | Skinfluencer diary 30-day skin diaries drive traffic to peruda.fr |
Clinical vault peruda.fr: ingredient science, Swiss study, dermatological approval |
Founder story Cancer survivor narrative creates emotional trust. NATRUE + UEBT from landing |
Mini set purchase CHF 65 Ritual Essentials — low-barrier gateway to the full system |
'Listen to your skin' AI-guided recovery. Community + expert support ecosystem |
Subscription renewal 82–96% gross margin. D2C flywheel accelerates from OTC brand building |
| E-pharmacyLafayette · Easypara · Atida · Cocoon | Marketplace listing Live on all 4 Tier 1 platforms. 860 units/month by M6 |
Reviews & ratings Marketplace social proof + clinical background on product pages |
Platform credibility Placement alongside certified dermocosmetics signals clinical intent |
First checkout Target: 4,400 units/month across all 4 platforms by month 18 |
Waterless ritual Different application — concentrated actives, no water dilution |
Reorder signal Platforms reordering unprompted — Phase 2 trigger condition |
| KOL & ClinicsDermatologists · Integrative · Rehab | KOL digital content French dermatologists with digital audiences. Swiss cases adapted |
Clinical evidence 4.3× dryness + 5.6× itch improvement vs control. Breast cancer study shared |
"I use this with my patients" KOL public endorsement — highest trust signal. Opens OTC doors |
Clinic recommendation Paramed, Sinological Physio, oncological skin therapists active in CH |
Measured improvement Follow-up shows visible results. Formal Swiss study from 2027 |
Patient advocate Word-of-mouth flywheel. Patient recommends to others |
| OTC PharmacyPhase 2 — Q4 2027 | By-name requests Customers ask for Peruda by name — Phase 2 condition met |
POS material Expanscience 60-person sales force trained |
Partner credibility Expanscience signals clinical intent to pharmacy buyers |
Pharmacy sale 500–600 premium POS. No incentives. Entry on Peruda terms |
Easy replenishment OTC removes friction. Pharmacist steers toward full routine |
Expanded basket New SKUs. Haircare + extended system from 2027 |